Try our Advanced Search for more refined results
July 10, 2019
NantKwest, Inc. et al v. Merck KGaA et al
Case Number:
3:19-cv-01266
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
August 21, 2019
Biotech Cos. Say Cancer-Killing Cell IP Fight Can Be Litigated
A California immunotherapy company argued Tuesday that it can't be forced to arbitrate a fee dispute stemming from a license agreement for a special line of cancer-killing cells, urging a federal court to hold there is no underlying arbitration agreement.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login